Lisa Eidenschink Brodersen

Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children’s Oncology Group

Richard Aplenc, Soheil Meshinchi, Lillian Sung et al. · Haematologica · 2020 · 166 citations · Full text

Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes—proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS

Anna Porwit, Arjan A. van de Loosdrecht, Peter Bettelheim et al. · Leukemia · 2014 · 145 citations

Hematological Malignancy, Flow Cytometry, Medicine +10

<i>CEBPA</i>-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children’s Oncology Group

Katherine Tarlock, Adam J. Lamble, Yi‐Cheng Wang et al. · Blood · 2021 · 119 citations · Full text

Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric <i>KMT2A</i> -Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531

Jessica A. Pollard, Erin Guest, Todd A. Alonzo et al. · Journal of Clinical Oncology · 2021 · 105 citations · Full text

Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group

Theresia M. Westers, Eline M.P. Cremers, Uta Oelschlaegel et al. · Haematologica · 2016 · 96 citations · Full text